向大脑巨细胞:NF-κB作为黑色素瘤大脑转移中的治疗门户
Martina Molgora1, Marco Colonna2
1H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Cancer cell
|March 11, 2025
概括
核因子kappa B (NF-κB) 子单元Rela驱动黑色素瘤大脑转移中的前瘤微质细胞. 向Rela重编程微质,改善抗瘤免疫力和T细胞反应,可能克服免疫疗法耐药性.
科学领域:
- 神经瘤学神经瘤学
- 癌症免疫学 癌症免疫学
- 分子瘤学分子瘤学
背景情况:
- 黑色素瘤大脑转移 (MBM) 是一个重大的临床挑战,患者的预后不佳.
- 微质细胞,大脑的常驻免疫细胞,在MBM的瘤微环境中发挥着关键作用.
- 在MBM中控制微质的前瘤功能的分子机制仍然不完全理解.
研究的目的:
- 调查核因子kappa B (NF-κB) 信号传递,特别是Rela子单元在调节黑色素瘤大脑转移的背景下微质细胞行为的作用.
- 通过评估其对微质表型和抗瘤免疫反应的影响,确定针对Rela在MBM中的治疗潜力.
主要方法:
- 利用基因工程的MBM小鼠模型来研究微质中的Rela的功能.
- 采用单细胞RNA测序和免疫组织化学等技术来分析微质细胞群及其与瘤细胞和T细胞的相互作用.
- 研究了人类巨细胞中RELA激活与免疫治疗反应之间的相关性.
主要成果:
- 确定Rela作为MBM中前瘤微质的关键驱动因素,促进免疫抑制瘤微环境.
- 证明了微质中Rela的删除将它们重新编程为一种促炎和抗转移的表型.
- 在微质中表现出增强的抗转移T细胞响应.
- 对抗癌症免疫治疗的人类巨细胞的相关RELA激活.
结论:
- 核因子kappa B (NF-κB) 子单元Rela是黑色素瘤大脑转移中的前瘤微质的关键调解者.
- 向微质中的Rela代表了一种有前途的治疗策略,以增强抗瘤免疫力并克服MBM的免疫疗法耐药性.
- 对微质中的Rela驱动通路的进一步研究可能会揭示MBM治疗的新目标.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Enzyme-linked Receptors
76.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.9K


